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ABSTRACT
The factors that control the consumption of oxygen and utili-
zation of energy by the heart have been of interest to cardio-
vascular physiologists and clinicians for many years. The
determinants of myocardial oxygen consumption (MV˙O2) have
warranted this careful consideration since, in the presence of
steady state conditions and with the obligatory aerobic nature of
myocardial metabolism, MV˙O2 serves as a measure of the total
energy utilization of the heart. Therefore, since utilization of
high energy phosphates, which constitute the immediate energy
source for contraction, is not readily determined directly, advan-
tage is taken of the close correlation between energy utilization
and MV˙O2, and the latter is measured experimentally. Further,
under clinical conditions that place a restraint on coronary blood
flow and, hence, on the availability of oxygen to the myocar-
dium, factors that alter MV˙O2 become a primary consideration.
A major advance in our understanding of the determinants of
MV˙O2 has come from an appreciation that cardiac muscle is
subject to the same general principles of control and analysis as
is skeletal muscle. Thus, the same factors that govern the
conversion of chemical energy into mechanical work in skeletal
muscle are important considerations in dealing with heart
muscle. In the present discussion the development of an integra-
tive concept of the determination of MV˙O2 will be reviewed,
and its relation to our present knowledge of muscle mechanics
will be assessed briefly. Such a synthesis may offer insight into
some of the apparent discrepancies and inconsistencies with
which the literature on the subject abounds and may provide a
more rational framework for understanding the dynamic control
of MV˙O2 in both physiologic and pathologic states.
Originally published in the American Journal of Cardiology, September
1968.
Review
My interest in the control of myocardial oxygen consump-
tion (MV˙O2) began in 1955, when as a postdoctoral fellow,
From Harvard Medical School, Partners HealthCare System and Brigham and
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50th Anniversary Historical Article
INTRODUCTION
In this edition of the Journal, we release the twelfth in a series
of reviews of influential articles that have been previously
published in ACC journals, including the American Journal of
Cardiology (from 1958 to 1982) and JACC (from 1983 to the
present). The publication of these articles is only one aspect of the
ACC’s 50th anniversary commemoration, which highlights 50
years of leadership in cardiovascular care and education. The
articles are intended to encourage reflection on the remarkable
progress made in cardiovascular medicine over time, as well as to
acknowledge the amazing prescience of some early investigators in
anticipating and, in many cases, later guiding developments in
their field.
The working group responsible for selecting these articles and
asking reviewers to write editorials solicited suggestions from
the ACC’s clinical committees and individual members.
The group achieved consensus fairly easily, including whom the
group should ask to prepare the accompanying editorials. We
initially drew up a list of 14 general areas to cover in this series,
but later found that there are several major areas of modern
cardiology, prominently molecular cardiology, in which the truly
landmark articles have, alas, not yet been published in JACC.
Therefore, the working group decided not to categorize by subject,
but instead, to concentrate on the most important articles.
The working group, a task force of the Subcommittee for the
Commemoration of the ACC 50th Anniversary, owes a great
deal to Ms. May A. Roustom and the efficient and tireless staff
at Heart House for facilitating this project. We also wish to
thank all who suggested articles and, most important, the
authors who prepared reviews for their willingness to contribute
their time and wisdom.
Influential Articles in JACC Working Group
Sharon A. Hunt, M.D., F.A.C.C.
Rick A. Nishimura, M.D., F.A.C.C.
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50th Anniversary Historical Article
I joined the team led by Stanley J. Sarnoff in the Laboratory
of Cardiovascular Physiology at the (then) National Heart
Institute to investigate the hemodynamic determinants of
this critical variable. The importance of MV˙O2 had been
appreciated since the work of Evans and Matsuoko (2) in
Ernest Starling’s laboratory at the beginning of the 20th
century. These investigators understood that the heart is an
aerobic organ and cannot (except for very brief periods)
develop an oxygen debt. However, there had been surpris-
ingly little research on this important aspect of cardiovas-
cular physiology for four decades, and we felt that if we
could “get a handle on” the determinants of MV˙O2, we
would gain important insights into the heart’s total meta-
bolic activity and could then relate this to its contractile
function.
Our first task was to develop a canine heart preparation in
which the key hemodynamic parameters (preload, afterload
and heart rate) could be accurately measured and indepen-
dently controlled. In the classical heart-lung preparation,
heart failure is progressive, but we needed to maintain
normal cardiac function over several hours. This would
avoid the confounding influence of progressive reductions of
contractility and of ventricular dilation on the relation
between cardiac contraction and energetics. Therefore, in
our “isolated supported heart preparation,” we used a sepa-
rate support dog whose circulation was in series with the
isolated heart and whose lungs served to oxygenate the
blood (3). The idea for this preparation had been sparked by
the technique of controlled cross circulation, which allowed
open-heart surgery to be performed before the perfection of
the heart-lung machine.
These experiments were both complex and costly; they
involved the use of a new generation of flow meters that
provided simultaneous and precise measurement of
cardiac output and coronary blood flow. Each experi-
ment took a team of eight investigators, post docs and
technicians about 18 h, and the manual analysis of
the records produced by the first eight-channel recorder
used in cardiovascular physiology took us another week
or so.
From this study we learned that at any heart rate,
intraventricular pressure was the most important determi-
nant of MV˙O2. The area under the left intraventricular
pressure curve, which we termed the “tension-time index,”
proved to be an even better correlate of MV˙O2 than the
peak pressure itself because this area takes account of the
important effects of heart rate and the relatively modest
effects of stroke volume (4). Having established the tension-
time index as a major determinant of MV˙O2, we went on to
demonstrate that MV˙O2, in turn, is the major determinant
of coronary blood flow (5). Subsequently, other investigators
devised techniques for calculating ventricular wall tension,
an even closer correlate of MV˙O2 than the tension-time
index (6).
Control of Myocardial
Oxygen Consumption:
Physiologic and Clinical Considerations
by E. Braunwald (7)
ABSTRACT
The basal oxygen consumption of the heart is small, approxi-
mately 20 percent of that of the contracting organ. Oxygen cost
of depolarization is approximately 0.5 percent of the total
oxygen consumed by the normally working heart. There is a far
greater oxygen cost of “pressure work” as opposed to “flow work,”
and a close relation between the area beneath the left ventricular
pressure curve, that is, the tension-time index, and myocardial
oxygen consumption. Also, the contractile state of the heart, as
reflected in the maximal velocity of isotonic shortening, is a
major determinant of myocardial oxygen consumption. Thus,
velocity of contraction shares the role of important determinant
of myocardial oxygen consumption with developed tension and
heart rate. Although the precise costs of activation and mainte-
nance of the active state of the myocardium have not yet been
clearly defined, it is likely that they are relatively low. In studies
on isolated papillary muscles, oxygen consumption was found to
be a function of the tension that is developed and the velocity of
shortening of the unloaded muscle. Shortening against a load
requires oxygen above and beyond that required for the devel-
opment of tension. Almost the entire increase in myocardial
oxygen consumption produced by the administration of cat-
echolamines results from the increased contractile activity pro-
duced rather than from a direct stimulating effect of the
catecholamines on myocardial metabolism. Severe valvular
regurgitation does not increase myocardial consumption signif-
icantly when myocardial tension is held constant. Congestive
heart failure is associated with depression of myocardial contrac-
tility, but this cannot be attributed to any reduction of high
energy phosphate stores in cardiac muscle. A technique for
reducing myocardial oxygen requirements by stimulating the
carotid sinus nerves is described and its application to the
treatment of angina pectoris demonstrated. It is also shown that
following coronary occlusion, interventions that increase myo-
cardial oxygen consumption appear to increase the size of the
infarction, whereas those that decrease myocardial oxygen con-
sumption reduce the size of the infarction.
Originally published in American Journal of Cardiology, April 1971.
Review
A decade later, I resumed studies of this subject with new
collaborators—John Ross, Edmund Sonnenblick, James
Covell, Neal Coleman, Tom Graham and others. In the
interim, principles of skeletal muscle mechanics had been
adapted to the heart. A second set of experiments was
carried out using a new canine preparation. With the dog on
total cardiopulmonary bypass, a balloon was placed into the
left ventricle so that it contracted isometrically; myocardial
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contractility was defined as the maximal velocity of calcu-
lated contractile element shortening, the so-called Vmax
(8). We demonstrated the importance of myocardial con-
tractility as the third key determinant of MV˙O2 (9,10) and
then extended our work to the isolated papillary muscle,
which allowed more precise measurement of myocardial
shortening (11). From this work and the work of other
investigators, we defined nine determinants of MV˙O2—the
“big three” (systolic wall tension, contractility and heart rate)
and six others (Table 1). These experiments were then
extended to dogs with experimentally-produced and quan-
tified valvular regurgitation (12).
An understanding of the determinants of MV˙O2 clarified
a number of previously puzzling clinical observations. For
example, the reduced levels of systolic wall tension in mitral
regurgitation explained the infrequency of ischemic mani-
festations in patients with this valvular abnormality. The
rarity of angina in patients with idiopathic dilated cardio-
myopathy and severe heart failure—despite the increase in
left ventricular volume and, therefore, in wall tension—
could be explained by the diminished myocardial contrac-
tility. A reduction of MV˙O2 through slowing of heart rate
and blockade of the stimulant effects of sympathetic influ-
ences on myocardial contractility was responsible for the
anti-anginal actions of the beta-adrenoreceptor blockers
when they were introduced. The reduction of MV˙O2
through a lowering of systolic intraventricular pressure (and
wall tension) explained, in part, the benefit of the recently
developed technique of intra-aortic balloon counterpulsa-
tion in some patients with acute myocardial ischemia.
The work of Suga (13) represents a major development
since the publication of these two papers in the American
Journal of Cardiology (the forerunner of the Journal of the
American College of Cardiology). This investigator found that
the left ventricular pressure-volume area (PVA) (i.e., the
area subtended by the left ventricular pressure-volume
curve) correlates even more closely with MV˙O2 than do
other variables. More recently, the PVA has been measured
in humans from left ventricular pressure-volume loops
(14,15). The imputed MV˙O2 at a PVA of zero is considered
to be the oxygen cost of excitation-contraction coupling; it
increases with the administration of beta adrenergic agonists
and decreases with impaired myocardial contractility (15).
Perhaps of greatest importance to me was that these
studies on MV˙O2 led my colleagues and me to attempt to
limit myocardial infarct size following coronary occlusion.
As stated in the 1971 paper:
“. . . An understanding of the determinants of myocardial
oxygen consumption is particularly relevant to patients with
acute myocardial infarction . . . Since the blood supply to
(the) ischemic segment of myocardium is markedly reduced,
its survival may depend on its oxygen needs. If the oxygen
requirement of the myocardium is stimulated by factors such
as increased tension, or contractility, or both, the viability of
the ischemic area may be reduced and the size of the infarct
enlarged . . .
“To test this hypothesis, branches of the left anterior
descending coronary artery were ligated in the open chest
dog and epicardial leads were recorded over the anterior
surface of the left ventricle before and after the occlusion.
Areas of ischemia, i.e., with elevations of the ST segment,
were observed in the direct distribution of the occluded
vessel . . . The augmentation of myocardial oxygen con-
sumption produced by stimulating myocardial contractility
with the administrations of positive inotropic agents such as
isoproterenol caused further elevation of ST seg-
ments . . . Conversely, the administration of a beta adren-
ergic blocking drug, propranolol, which blocks the stimu-
lating effects of adrenergic agents on the heart, would be
expected to lower myocardial oxygen demands, and in these
studies it was found to reduce the ST-segment elevations
occurring during coronary occlusion. It was of considerable
interest that changes in myocardial oxygen consumption pro-
duced as late as 3 hours after coronary occlusion altered the area
of ischemic injury. (my current emphasis) . . .
“Reduction of myocardial oxygen demands produced by
slowing the heart rate and counteracting the augmentation
of sympathetic influences may reduce oxygen demands and
thereby the size of the infarction.” (my current emphasis)
These observations led to a long string of experiments in
the dog and rat, conducted first with the late Peter Maroko
and subsequently with James Muller and Robert Kloner, in
which a variety of interventions—including myocardial
reperfusion—were shown to be effective in limiting myo-
cardial damage following coronary occlusion (16). These
experiments, in turn, led to our efforts in the TIMI
(Thrombolysis in Myocardial Infarction) trials to improve
clinical outcome with thrombolytic therapy early in the
course of myocardial infarction (17).
In 1955, when we began our work on elucidating the
determinants of MV˙O2, we did not appreciate its potential
clinical relevance. At that time, our experiments were
categorized as basic physiologic research, of little if any
clinical import. Their potential clinical significance became
clear only after a latent period of about 15 years (55 years if
we take as the starting point the 1915 experiments of Evans
and Matsuoko [2] referred to previously). It is gratifying to
me that we now live in an era in which there is great
encouragement for investigators to accelerate “bench to
bedside” translation.
Table 1. Determinants of Myocardial Oxygen Consumption
1. Tension development
2. Contractile state
3. Heart rate
4. Basal cost
5. Depolarization
6. Direct metabolic effect of catecholamines
7. Activation
8. Maintenance of active state
9. Shortening against a load–Fenn effect
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